Hepatic steatosis is associated with greater noncalcified plaque burden (NCPB) and an increased risk for a MACE.
India, June 2 -- A large multicenter clinical trial has found that individuals with hepatic steatosis-commonly known as fatty ...
It's "not only a liver condition but also an important marker of heart disease risk,” says one of the study's authors.
Individuals with hepatic steatosis appeared to have higher amounts of noncalcified coronary plaque and were almost twice as ...
A new large clinical study reveals that fatty liver disease is strongly linked to dangerous coronary artery plaque and nearly double the risk of heart attacks and cardiovascular events.